| Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options | Pharmacological Reviews | 2020 | 121 |
| The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017 | Lancet Public Health, The | 2020 | 101 |
| CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity | Environmental Health Perspectives | 2020 | 70 |
| Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab | Immunobiology | 2020 | 64 |
| Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials | Lancet Oncology, The | 2020 | 55 |
| Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020 | Lancet, The | 2020 | 51 |
| Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events | JACC: Cardiovascular Imaging | 2020 | 32 |
| Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? | Epilepsia | 2020 | 29 |
| Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group | Blood | 2020 | 23 |
| Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial | European Journal of Heart Failure | 2020 | 22 |
| The Expiry of Humira Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures | Frontiers in Pharmacology | 2020 | 21 |
| Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial | Trials | 2020 | 18 |
| First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis | Blood Advances | 2020 | 17 |
| JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function | Circulation Research | 2020 | 17 |
| PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer | International Journal of Molecular Sciences | 2020 | 15 |
| Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions | Frontiers in Immunology | 2020 | 12 |
| Physiological and Transcriptional Effects of Mixtures of Environmental Estrogens, Androgens, Progestins, and Glucocorticoids in Zebrafish | Environmental Science & Technology | 2020 | 10 |
| Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia | Cells | 2020 | 10 |
| Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM) | Journal of Gastrointestinal Surgery | 2020 | 9 |
| Effects of new generation progestins, including as mixtures and in combination with other classes of steroid hormones, on zebrafish early life stages | Science of the Total Environment | 2020 | 9 |
| Alzheimer's disease: from basic science to precision medicine approach | BMJ Neurology Open | 2020 | 9 |
| Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation | Nutrients | 2020 | 7 |
| Comorbidity does not mean clinical complexity: evidence from the RePoSI register | Internal and Emergency Medicine | 2020 | 7 |
| Ecotoxicological effects of atmospheric particulate produced by braking systems on aquatic and edaphic organisms | Environment International | 2020 | 6 |
| The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients. | Journal of Clinical Oncology | 2020 | 6 |
